Page last updated: 2024-10-15

chromomycins

Description

Chromomycins: A complex of several closely related glycosidic antibiotics from Streptomyces griseus. The major component, CHROMOMYCIN A3, is used as a fluorescent stain of DNA where it attaches and inhibits RNA synthesis. It is also used as an antineoplastic agent, especially for solid tumors. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

chromomycin : A family of antibiotics isolated from Streptomyces griseus. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID131750203
MeSH IDM0004396

Synonyms (3)

Synonym
chromomycin
74913-06-7
chromomycins

Toxicity

ExcerptReference
" However, the concentrations of these drugs which produced similar mutagenic or DNA strand break responses differed greatly for cells from the three species, and a good correlation was observed between the toxic and the mutagenic concentrations of these drugs for cells from the three species examined."( Species-specific differences in the toxicity and mutagenicity of the anticancer drugs mithramycin, chromomycin A3, and olivomycin.
Gupta, RS; Singh, B, 1985
)
" Distamycin A readily inhibited nucleic acid and protein synthesis and was more toxic to the ring stage than to the trophozoite stage in various parasite strains, irrespective of their susceptibility to chloroquine."( Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
Ginsburg, H; Krugliak, M; Nissani, E; Williamson, DH, 1993
)

Compound-Compound Interactions

ExcerptReference
"A striking chemotherapeutically curative effect on tumor was obtained by means of temporary interruption of regional blood flow combined with local hyperthermia."( Temporary interruption of regional blood flow combined with local hyperthermia for cancer chemotherapy.
Aoki, K; Baba, T; Kanematsu, T; Kidera, Y; Kimura, M, 1976
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (166)

TimeframeStudies, This Drug (%)All Drugs %
pre-199094 (56.63)18.7374
1990's35 (21.08)18.2507
2000's18 (10.84)29.6817
2010's15 (9.04)24.3611
2020's4 (2.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (3.43%)6.00%
Case Studies1 (0.57%)4.05%
Observational0 (0.00%)0.25%
Other168 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]